DVLA Stock Overview
Engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
PT Darya-Varia Laboratoria Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp1,635.00 |
| 52 Week High | Rp1,850.00 |
| 52 Week Low | Rp1,375.00 |
| Beta | -0.086 |
| 1 Month Change | 0% |
| 3 Month Change | -4.94% |
| 1 Year Change | -0.61% |
| 3 Year Change | -40.76% |
| 5 Year Change | -26.35% |
| Change since IPO | 92.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| DVLA | ID Pharmaceuticals | ID Market | |
|---|---|---|---|
| 7D | 0.3% | -9.6% | -3.6% |
| 1Y | -0.6% | -23.0% | 2.7% |
Return vs Industry: DVLA exceeded the ID Pharmaceuticals industry which returned -23% over the past year.
Return vs Market: DVLA underperformed the ID Market which returned 2.7% over the past year.
Price Volatility
| DVLA volatility | |
|---|---|
| DVLA Average Weekly Movement | 2.7% |
| Pharmaceuticals Industry Average Movement | 4.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.8% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: DVLA has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: DVLA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 1,266 | n/a | www.darya-varia.com |
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company provides prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems.
PT Darya-Varia Laboratoria Tbk Fundamentals Summary
| DVLA fundamental statistics | |
|---|---|
| Market cap | Rp1.83t |
| Earnings (TTM) | Rp193.91b |
| Revenue (TTM) | Rp2.13t |
9.4x
P/E Ratio0.9x
P/S RatioIs DVLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DVLA income statement (TTM) | |
|---|---|
| Revenue | Rp2.13t |
| Cost of Revenue | Rp1.01t |
| Gross Profit | Rp1.12t |
| Other Expenses | Rp930.93b |
| Earnings | Rp193.91b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 173.13 |
| Gross Margin | 52.71% |
| Net Profit Margin | 9.09% |
| Debt/Equity Ratio | 0% |
How did DVLA perform over the long term?
See historical performance and comparisonDividends
6.6%
Current Dividend Yield62%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 23:51 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PT Darya-Varia Laboratoria Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|